{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:16:59Z","timestamp":1762507019428,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T00:00:00Z","timestamp":1527292800000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1T32-CA180984"],"award-info":[{"award-number":["1T32-CA180984"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CMMI 1536444"],"award-info":[{"award-number":["CMMI 1536444"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.urology.2017.01.039","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T21:00:48Z","timestamp":1487797248000},"page":"137-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Evaluation of Prostate Cancer Risk Calculators for Shared Decision Making Across Diverse Urology Practices in Michigan"],"prefix":"10.1016","volume":"104","author":[{"given":"Gregory B.","family":"Auffenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selin","family":"Merdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8344-7972","authenticated-orcid":false,"given":"Benjamin R.","family":"Stockton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khurshid R.","family":"Ghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian T.","family":"Denton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2017.01.039_bib0010","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1056\/NEJMp1510020","article-title":"Shared decision making\u2014finding the sweet spot","volume":"374","author":"Fried","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2017.01.039_bib0015","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.juro.2013.04.119","article-title":"Early detection of prostate cancer: AUA guideline","volume":"190","author":"Carter","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.01.039_bib0020","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.urpr.2015.10.006","article-title":"AUA white paper on implementation of shared decision making into urological practice","volume":"3","author":"Makarov","year":"2016","journal-title":"Urol Pract"},{"key":"10.1016\/j.urology.2017.01.039_bib0025","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jnci\/djj131","article-title":"Assessing prostate cancer risk: results from the prostate cancer prevention trial","volume":"98","author":"Thompson","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urology.2017.01.039_bib0030","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.urology.2014.02.035","article-title":"Prostate cancer prevention trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer","volume":"83","author":"Ankerst","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.urology.2017.01.039_bib0040","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/sim.6114","article-title":"Assessing calibration of multinomial risk prediction models","volume":"33","author":"Van Hoorde","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.urology.2017.01.039_bib0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00345-012-0869-2","article-title":"Evaluating the prostate cancer prevention trial high grade prostate cancer risk calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group","volume":"32","author":"Ankerst","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2017.01.039_bib0050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.juro.2015.03.126","article-title":"A statewide intervention to reduce hospitalizations after prostate biopsy","volume":"194","author":"Womble","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.01.039_bib0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.eururo.2014.08.024","article-title":"Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer","volume":"67","author":"Womble","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2017.01.039_bib0060","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.juro.2016.05.095","article-title":"Comparison of pathological outcomes for men with low risk prostate cancer from diverse practice settings: similar results from immediate prostatectomy or initial surveillance with delayed prostatectomy","volume":"196","author":"Auffenberg","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.01.039_bib0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1010920819831","article-title":"A simple generalisation of the area under the ROC curve for multiple class classification problems","volume":"45","author":"Hand","year":"2001","journal-title":"Mach Learn"},{"key":"10.1016\/j.urology.2017.01.039_bib0070","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/bju.13437","article-title":"European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators significantly outperform the Prostate Cancer Prevention Trial (PCPT) 2.0 in the prediction of prostate cancer: a multi-institutional study","volume":"118","author":"Foley","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2017.01.039_bib0075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bju.13314","volume":"117","author":"Poyet","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2017.01.039_bib0080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jbi.2015.05.001","article-title":"Improving patient prostate cancer risk assessment: moving from static, globally-applied to dynamic, practice-specific risk calculators","volume":"56","author":"Strobl","year":"2015","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.urology.2017.01.039_bib0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thompson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2017.01.039_bib0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eururo.2015.04.039","article-title":"Urine TMPRSS2:ERG Plus PCA3 for individualized prostate cancer risk assessment","volume":"70","author":"Tomlins","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2017.01.039_bib0095","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/pros.23191","article-title":"Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies","volume":"76","author":"Van Neste","year":"2016","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2017.01.039_bib0100","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1158\/1055-9965.EPI-07-0302","article-title":"Assessment of 54 biomarkers for biopsy-detectable prostate cancer","volume":"16","author":"Parekh","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urology.2017.01.039_bib0105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urology.2017.01.039_bib0110","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jamaoncol.2016.2667","article-title":"Prostate cancer incidence rates 2 years after the Us preventive services task force recommendations against screening","volume":"2","author":"Jemal","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.urology.2017.01.039_bib0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.6004\/jnccn.2016.0004","article-title":"Prostate cancer, version 1.2016","volume":"14","author":"Mohler","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.urology.2017.01.039_bib0120","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1200\/JCO.2015.61.6532","article-title":"National prostate cancer screening rates after the 2012 US preventive services task force recommendation discouraging prostate-specific antigen-based screening","volume":"33","author":"Drazer","year":"2015","journal-title":"J Clin Oncol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429517301656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429517301656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:58:22Z","timestamp":1758765502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429517301656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":22,"alternative-id":["S0090429517301656"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2017.01.039","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Prostate Cancer Risk Calculators for Shared Decision Making Across Diverse Urology Practices in Michigan","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2017.01.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}